Radiofrequency platform

IgniteRF

Face and body. Precision in the plan.

Multi-applicator radiofrequency platform for minimally invasive face and body remodeling.

Your medical assessment determines suitability.
IgniteRF by InMode — RF soft-tissue remodeling platform
InMode
About the technology

Understand the platform.

RF soft-tissue remodeling platform

Manufacturer information
  • 010.5–60 mm treatment-depth range
  • 02Bipolar RF modalities
  • 03Temperature + impedance feedback

Areas of application

Soft-tissue contraction · Facial remodeling · Body contouring

An informed choice.

What the evidence can tell you — and where its limits matter.

Sources checked

Evidence & expectations

RF microneedling introduces electrodes into tissue; it is different from external RF heating. Any proposed benefit needs to be considered alongside the actual needle depth, applicator and treated area. A platform name alone does not describe the procedure.[1]

A systematic review found measurable laxity improvements with monopolar and bipolar RF across several devices. Techniques, study designs and follow-up varied. These findings do not prove that different platforms are equivalent or that RF reproduces a surgical lift.[2]

Preparation & recovery

Ask whether the proposed treatment punctures the skin, what anaesthesia and aftercare it needs and how to contact the clinician during healing. Do not infer recovery from an external-RF treatment.[1]

Discuss implants, previous procedures and any condition affecting the treatment area. Ask what sensations and visible changes to expect, and how the proposed applicator determines recovery and follow-up.[3]

Risks & limitations

In October 2025 the FDA highlighted reports of burns, scarring, fat loss, nerve damage and disfigurement with certain RF-microneedling uses. These are material risks to discuss, not effects that can be excluded by describing treatment as minimally invasive.[1]

Energy-based procedures can cause pain, swelling, burns or unwanted tissue effects. Eligibility and risks depend on the modality and body site. Non-invasive does not mean risk-free or equivalent to surgery.[3]

Compare your options

A surface-texture goal, a deeper soft-tissue goal and a surgical correction are different decisions. Compare the proposed depth and risks with fractional laser or non-invasive options before selecting a procedure.[2][4]

Discuss whether the main issue is laxity, volume, muscle movement or a surface change. Ultrasound, injectables and laser treatments target different structures; a combined plan should explain the added purpose and burden of each step.[2]

Different approaches to discuss

These links explain different targets. They are not personalised recommendations.

Morpheus8 RF microneedlingPicoSure Pro FocusUltraClear Laser-CoringK-LUXE

Sources & further reading

  1. Regulatory safety informationPotential risks with certain uses of RF microneedlingFDA · 2025
  2. Systematic reviewMonopolar and bipolar radiofrequency for skin tightening: systematic reviewRohrich et al. · Plastic and Reconstructive Surgery · 2022
  3. Regulatory safety informationNon-invasive body contouring technologiesFDA
  4. Clinical study755 nm picosecond laser with a specialized optic for acne scarsBrauer et al. · JAMA Dermatology · 2015
  5. Manufacturer informationIgniteRF: platform informationInModeManufacturer information explains the platform or named protocol; it is not independent evidence of clinical benefit.
How we use evidence

A controlled trial compares interventions in defined groups; an uncontrolled cohort cannot, alone, establish causality. A review depends on the quality of its included studies. We distinguish these sources from manufacturer information and identify when findings do not directly apply to the platform or protocol.

The date records when sources were checked for this guide. It is not a statement of individual clinical review, product authorisation or confirmation of the clinic’s available configuration.

This guide supports a conversation with your clinician. It does not determine your suitability or replace individual aftercare instructions.

Regulatory sources describe their own jurisdictions; a US authorisation or warning does not determine a product’s legal status in Portugal.